NEBNext Direct employs a unique technology that enables highly specific target enrichment of genomic regions of interest. The result of a partnership between New England Biolabs® (NEB®) and Directed Genomics™, this innovative approach to target enrichment balances the speed and precision of multiplexed PCR-based approaches with the content scalability typical of hybridization-based methods. This flexibility allows a single workflow for assays ranging from single gene tests to comprehensive panels including several hundred genes. Regardless of sample type or assay content, NEBNext Direct allows you to enrich your targets with precision.
Try NEBNext Direct for yourself. Request a NEBNext Direct sample.
For more information, please contact NEBNextDirect@neb.com.
Learn more about the NEBNext Direct Cancer HotSpot Panel and view performance data.
NEW ENGLAND BIOLABS® and NEB® are registered trademarks of New England Biolabs, Inc.
NEBNext Direct® is a trademark of New England Biolabs, Inc.
Directed Genomics™ is a trademark of Directed Genomics